We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
-15.55%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$1.72B
AUM Growth
-$127M
Cap. Flow
+$291M
Cap. Flow %
16.93%
Top 10 Hldgs %
29.42%
Holding
147
New
37
Increased
70
Reduced
4
Closed
12

Top Buys

Rank Stock Value
1
TERP
TerraForm Power, Inc
TERP
+$33.5M
2
PANW icon
Palo Alto Networks
PANW
+$23.1M
3
SUNE
SUNEDISON, INC COM
SUNE
+$22.5M
4
QLIK
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
+$17.8M
5
SPWR
SunPower Corporation Common Stock
SPWR
+$15.8M

Top Sells

Rank Stock Value
1
MNDT
Mandiant, Inc. Common Stock
MNDT
+$40.5M
2
TRN icon
Trinity Industries
TRN
+$24.1M
3
NRG icon
NRG Energy
NRG
+$19.6M
4
TEX icon
Terex
TEX
+$13M
5
TTPH
Tetraphase Pharmaceuticals, Inc.
TTPH
+$4.26M

Sector Composition

Rank Sector Weight
1 Healthcare 27.33%
2 Technology 24.49%
3 Consumer Discretionary 14.42%
4 Industrials 7.04%
5 Real Estate 4.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
76
Travere Therapeutics
TVTX
$5.33B
$4.88M 0.28%
240,600
+75,500
+46% +$2.24M
GLBL
77
DELISTED
TerraForm Global, Inc. Class A Common Stock
GLBL
$4.53M 0.26%
+680,400
New +$6.59M
XNCR icon
78
Xencor
XNCR
$1.59B
$4.48M 0.26%
366,600
+38,900
+12% +$761K
CMRE icon
79
Costamare
CMRE
$1.87B
$4.42M 0.26%
360,200
– –
CEMP
80
DELISTED
Cempra, Inc.
CEMP
$4.37M 0.25%
156,800
+3,000
+2% +$111K
ATRC icon
81
AtriCure
ATRC
$2.04B
$4.03M 0.23%
184,100
+31,800
+21% +$795K
PRTA icon
82
Prothena Corp
PRTA
$440M
$3.95M 0.23%
+87,172
New +$5.08M
TCON
83
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$3.95M 0.23%
+2,020
New +$4.72M
TGTX icon
84
TG Therapeutics
TGTX
$8.19B
$3.79M 0.22%
375,800
+104,700
+39% +$1.56M
CAFD
85
DELISTED
8point3 Energy Partners LP
CAFD
$3.54M 0.21%
+334,100
New +$5.08M
ZSAN
86
DELISTED
Zosano Pharma Corporation
ZSAN
$3.5M 0.2%
1,263
+8
+0.6% +$44.9K
AGTC
87
DELISTED
Applied Genetic Technologies Corporation
AGTC
$3.29M 0.19%
250,500
+45,000
+22% +$746K
CSLT
88
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$3.29M 0.19%
783,600
+233,000
+42% +$1.47M
MCRB icon
89
Seres Therapeutics
MCRB
$46.3M
$3.19M 0.19%
+5,377
New +$4.39M
QURE icon
90
uniQure
QURE
$2.93B
$3.17M 0.18%
154,900
+64,400
+71% +$1.7M
SGMO
91
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$2.72M 0.16%
482,500
– –
INSM icon
92
Insmed
INSM
$22B
$2.69M 0.16%
144,600
+56,000
+63% +$1.4M
DRNA
93
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$2.59M 0.15%
315,300
+40,000
+15% +$462K
OMED
94
DELISTED
OncoMed Pharmaceuticals, Inc.
OMED
$2.44M 0.14%
146,900
+61,800
+73% +$1.24M
CLDX icon
95
Celldex Therapeutics
CLDX
$3.02B
$2.41M 0.14%
15,253
-3,994
-21% -$1.13M
BPMC
96
DELISTED
Blueprint Medicines
BPMC
$2.28M 0.13%
+107,000
New +$2.96M
CDTX
97
DELISTED
Cidara Therapeutics
CDTX
$2.23M 0.13%
8,770
+2,639
+43% +$754K
XLRN
98
DELISTED
Acceleron Pharma
XLRN
$2.17M 0.13%
87,100
– –
ONCE
99
DELISTED
Spark Therapeutics, Inc. Common Stock
ONCE
$2.04M 0.12%
49,000
+10,800
+28% +$564K
IMDZ
100
DELISTED
Immune Design Corp.
IMDZ
$1.89M 0.11%
154,501
+51,597
+50% +$967K
2 3
4
5 6

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q3 2015 Portfolio in Review

As of Q3 2015, Eventide Asset Management held 147 positions worth $1.72B, down 6.9% from $1.85B the previous quarter. Its ten largest holdings account for 29% of the portfolio.

Eventide Asset Management deployed $291M of net new capital in Q3 2015, opening 37 new positions and adding to 70 existing holdings. Its largest new stake was TerraForm Power, Inc: 1,249,550 shares worth $17.8M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Tetraphase Pharmaceuticals, Inc., an estimated $4.26M trimmed.

  • Eventide Asset Management's largest Q3 2015 buy was TerraForm Power, Inc: 1,249,550 shares worth $17.8M.
  • Eventide Asset Management added most to Palo Alto Networks in Q3 2015, an estimated $23.1M increase.
  • Eventide Asset Management's biggest Q3 2015 reduction was Tetraphase Pharmaceuticals, Inc., cutting an estimated $4.26M.
  • Eventide Asset Management fully exited Mandiant, Inc. Common Stock in Q3 2015, selling an estimated $40.5M.
  • Eventide Asset Management's ten largest holdings make up 29% of its $1.72B portfolio in Q3 2015.
  • Eventide Asset Management opened 37 new positions and closed 12 in Q3 2015.
  • Eventide Asset Management's portfolio value fell 6.9% quarter-over-quarter to $1.72B.

Based on Eventide Asset Management's 13F filing for Q3 2015, filed 13 Nov 2015.